Skip to main content
CING
NASDAQ Life Sciences

Cingulate Inc. Expands At-The-Market Offering to Raise Up to $8.84 Million, Signaling Significant Dilution

Analyse IA par Wiseek
Sentiment info
Negatif
Importance info
8
Prix
$4.84
Cap. de marche
$32.907M
Plus bas 52 sem.
$3.2
Plus haut 52 sem.
$6.01
Market data snapshot near publication time

summarizeResume

Cingulate Inc. has expanded its At-The-Market (ATM) offering capacity, allowing it to sell up to an additional $8.84 million in common stock. This represents a substantial potential dilution for existing shareholders, given the company's current market capitalization. While raising capital is crucial for extending the company's operational runway, the continuous sale of shares through an ATM program can create an overhang on the stock price. Investors should monitor the pace and pricing of these sales as they occur.


check_boxEvenements cles

  • Expanded ATM Offering

    Cingulate Inc. can now sell up to an additional $8.84 million of common stock through its At-The-Market (ATM) offering program.

  • Significant Potential Dilution

    The potential capital raise of $8.84 million is substantial relative to the company's market capitalization, indicating significant potential dilution for current shareholders.

  • Ongoing Capital Strategy

    This filing updates a previously established ATM program, under which the company has already sold approximately $15.15 million in shares.


auto_awesomeAnalyse

Cingulate Inc. has expanded its At-The-Market (ATM) offering capacity, allowing it to sell up to an additional $8.84 million in common stock. This represents a substantial potential dilution for existing shareholders, given the company's current market capitalization. While raising capital is crucial for extending the company's operational runway, the continuous sale of shares through an ATM program can create an overhang on the stock price. Investors should monitor the pace and pricing of these sales as they occur.

Au moment de ce dépôt, CING s'échangeait à 4,84 $ sur NASDAQ dans le secteur Life Sciences, pour une capitalisation boursière d'environ 32,9 M $. La fourchette de cours sur 52 semaines allait de 3,20 $ à 6,01 $. Ce dépôt a été évalué avec un sentiment de marché négatif et un score d'importance de 8 sur 10.

descriptionVoir le depot SEC principal

show_chartGraphique des prix

Partager cet article

Copied!

feed CING - Dernieres analyses

CING
Apr 28, 2026, 4:24 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Apr 14, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 27, 2026, 4:01 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Mar 26, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
CING
Mar 24, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
9
CING
Mar 24, 2026, 5:13 PM EDT
Filing Type: 424B3
Importance Score:
9
CING
Mar 19, 2026, 6:00 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 18, 2026, 4:30 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CING
Mar 18, 2026, 8:13 AM EDT
Filing Type: 10-K
Importance Score:
9
CING
Mar 18, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
9